Publications by authors named "Susan Schwager"

Claim this Profile
T
The role of imaging studies in predicting time to first treatment and overall survival in high-count monoclonal B-cell lymphocytosis.
Samuel Kosydar, William J Archibald, Paul J Hampel, Timothy G Call, Sara J Achenbach, Susan M Schwager

Br J Haematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma in the targeted therapy era.
Paul J Hampel, Kari G Rabe, Yucai Wang, Steven R Hwang, Saad S Kenderian, Susan M Schwager

Leukemia· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia who develop venous thromboembolism.
Amber B Koehler, Kari G Rabe, Daniel J Crusan, Timothy G Call, Sara J Achenbach, Susan M Schwager

J Thromb Haemost· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell multiomics reveal divergent effects of DNMT3A- and TET2-mutant clonal hematopoiesis in inflammatory response.
Wazim Mohammed Ismail, Jenna A Fernandez, Moritz Binder, Terra L Lasho, Minsuk Kim, Susan M Schwager

Blood Adv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of radiotherapy for second primary malignancies in patients with chronic lymphocytic leukemia receiving concurrent novel agent treatment.
Samuel R Kosydar, Sameer A Parikh, Scott C Lester, Kari G Rabe, Wei Ding, Susan M Schwager

Am J Hematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined ibrutinib and venetoclax for treatment of patients with ibrutinib-resistant or double-refractory chronic lymphocytic leukaemia.
Paul J Hampel, Kari G Rabe, Timothy G Call, Wei Ding, Jose F Leis, Susan M Schwager

Br J Haematol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib.
Paul J Hampel, Kari G Rabe, Timothy G Call, Wei Ding, Jose F Leis, Susan M Schwager

Blood Cancer J· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic lymphocytic leukemia (CLL) with Reed-Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?
Rebecca L King, Alia Gupta, Paul J Kurtin, Wei Ding, Timothy G Call, Susan M Schwager

Blood Cancer J· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index.
Yucai Wang, Sara J Achenbach, Kari G Rabe, Tait D Shanafelt, Timothy G Call, Susan M Schwager

Blood Cancer J· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL.
Sameer A Parikh, Kari G Rabe, Neil E Kay, Timothy G Call, Wei Ding, Susan M Schwager

Blood· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic significance of del6q23 in chronic lymphocytic leukemia.
Hadiyah Y Audil, Paul J Hampel, Daniel L Van Dyke, Sara J Achenbach, Kari G Rabe, Susan M Schwager

Am J Hematol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia.
Paul J Hampel, Sameer A Parikh, Timothy G Call, Mithun V Shah, N Nora Bennani, Susan M Schwager

Blood Cancer J· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of serious infection among individuals with and without low count monoclonal B-cell lymphocytosis (MBL).
Tait D Shanafelt, Neil E Kay, Sameer A Parikh, Sara J Achenbach, Connie E Lesnick, Susan M Schwager

Leukemia· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes.
William J Archibald, Kari G Rabe, Brian F Kabat, Joerg Herrmann, Wei Ding, Susan M Schwager

Ann Hematol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia.
Paul J Hampel, Timothy G Call, Kari G Rabe, Wei Ding, Eli Muchtar, Susan M Schwager

Oncologist· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of 18F-FDG-PET in detecting Richter's transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor.
Yucai Wang, Kari G Rabe, Michael S Bold, Min Shi, Curtis A Hanson, Susan M Schwager

Haematologica· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practice.
Amber B Koehler, Nelson Leung, Timothy G Call, Kari G Rabe, Sara J Achenbach, Susan M Schwager

Leuk Lymphoma· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice.
Sameer A Parikh, Sara J Achenbach, Timothy G Call, Kari G Rabe, Wei Ding, Susan M Schwager

Cancer Med· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center.
Yucai Wang, Marcella A Tschautscher, Kari G Rabe, Timothy G Call, Jose F Leis, Susan M Schwager

Haematologica· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare.
Paul J Hampel, Timothy G Call, Wei Ding, Eli Muchtar, Saad S Kenderian, Susan M Schwager

Am J Hematol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice.
Paul J Hampel, Wei Ding, Timothy G Call, Kari G Rabe, Saad S Kenderian, Susan M Schwager

Leuk Lymphoma· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes.
Hong Fang, Kaaren K Reichard, Kari G Rabe, Curtis A Hanson, Timothy G Call, Susan M Schwager

Am J Hematol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre.
Paul J Hampel, Melissa C Larson, Brian Kabat, Timothy G Call, Wei Ding, Susan M Schwager

Br J Haematol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis.
Sameer A Parikh, Kari G Chaffee, Melissa C Larson, Paul J Hampel, Timothy G Call, Susan M Schwager

Haematologica· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings.
Paul J Hampel, Kari G Chaffee, Rebecca L King, Douglas Simonetto, Melissa C Larson, Susan M Schwager

Am J Hematol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis